We are grateful to the The American Cancer Society (ACS) as well as Yosemite, an oncology-focused venture capital firm, for their generous support of our work on epigenetic reprogramming of adoptive cell therapies to bolster memory formation. The ACS-Yosemite awards support innovative work in immuno-oncology as well as the use of Artificial Intelligence (AI) in cancer prevention, detection, treatment, and healthcare delivery.
Support from the Yosemite-American Cancer Society